Craft
  • Home
  •  / OncoMed Pharmaceuticals
OncoMed Pharmaceuticals

OncoMed Pharmaceuticals

Revenue

$44.4 M

FY, 2018

OncoMed Pharmaceuticals Summary

Company summary

Overview
OncoMed is a clinical-stage biopharmaceutical company focused on discovering and developing therapeutic candidates directed to fundamental biologic pathways and targets thought to drive cancer’s growth, resistance, recurrence, and metastasis. The company offers several therapeutic candidates specifically targeting cancer stem cell pathways and it has an emerging pipeline of immuno-oncology therapeutic candidates that aim to bolster immune system recognition of cancer cells and/or suppress immune system evasion mechanisms.
Type
Subsidiary
Founded
2004
HQ
Redwood City, CA, US | view all locations
Website
http://www.oncomed.com/
Cybersecurity rating
Sectors

Key people

  • Austin Gurney

    Austin Gurney, Senior Vice President, Molecular and Cellular Biology

    • Jill Henrich

      Jill Henrich, Vice President, Regulatory Affairs

    • Alicia J. Hager

      Alicia J. Hager, Vice President, General Counsel

    • Tim Hoey

      Tim Hoey, Senior Vice President, Cancer Biology

    LocationsView all

    1 location detected

    • Redwood City, CA HQ

      United States

      800 Chesapeake Dr

    OncoMed Pharmaceuticals Financials

    Summary financials

    Revenue (FY, 2018)
    $44.4M
    Net income (FY, 2018)
    ($8.1M)
    Cash (FY, 2018)
    $9.7M
    EBIT (FY, 2018)
    ($10.0M)

    Footer menu